Want to see MTNB full AI Analyst Report?
Matinas BioPharma (MTNB) Q2 2023 Earnings Report
MTNB Q2 2023 EPS Results
- Actual EPS
- -$22.50
- Consensus EPS
- -$22.76
- Beat/Miss
- Beat by +$0.26
- One Year Ago EPS
- -$22.50
MTNB Q2 2023 Revenue Results
- Actual Revenue
- $0
- Expected Revenue
- $300.00K
- Beat/Miss
- Missed by -$300.00K
- YoY Revenue Growth
- -100.00%
Earnings Announcement Details
- Quarter
- Q2 2023
- Date
- 08/09/2023
- Time
- After Close
- Conference Call
- Wednesday, August 9, 2023
Q2 2023 Earnings Call Audio
MTNB Q2 2023 Earnings Call
0:00 / 0:00
Q2 2023 Earnings Slide Deck
No slide deck is available for this earnings event.
Q2 2023 Earnings Call Summary
No earnings call summary is available for this earnings event.
MTNB Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| May 07, 2026 | 2026 (Q1) | ―-0.30 | -0.33 | 7.98% (+0.03) | |
| Aug 19, 2025 | 2025 (Q2) | ―-1.03 | -1 | -3.10% (-0.03) | |
| May 08, 2025 | 2025 (Q1) | ―-0.33 | -1.5 | 78.27% (+1.17) | |
| Mar 18, 2025 | 2024 (Q4) | -0.78-1.66 | -1 | -65.80% (-0.66) | |
| Nov 06, 2024 | 2024 (Q3) | -1.05-0.85 | -1.5 | 43.33% (+0.65) | |
| Aug 14, 2024 | 2024 (Q2) | -18.75-15.00 | -22.5 | 33.33% (+7.50) | |
| May 09, 2024 | 2024 (Q1) | -22.50-22.50 | -22.5 | 0.00% (+0.00) | |
| Mar 27, 2024 | 2023 (Q4) | -22.50-15.00 | -15 | 0.00% (+0.00) | |
| Nov 08, 2023 | 2023 (Q3) | -21.79-22.50 | -22.5 | 0.00% (+0.00) | |
| Aug 09, 2023 | 2023 (Q2) | -22.76-22.50 | -22.5 | 0.00% (+0.00) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed
